C. Aul
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 24
- Acute Myeloid Leukemia Research 18
- Multiple Myeloma Research and Treatments 5
-
- Retinoids in leukemia and cellular processes 4
- Co-authors
- Norbert Gattermann (12 shared papers)Wolfgang Schneider (12 shared papers)Ulrich Germing (10 shared papers)A. Heyll (15 shared papers)G. Derigs (1 shared paper)Volker Runde (6 shared papers)D. Söhngen (8 shared papers)W Schneider (2 shared papers)
- Journals
- Leukemia Research (4 papers)Annals of Hematology (2 papers)Blood (1 paper)Haematologica (1 paper)Leukemia (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
C. Aul
33 papers receiving 732 citations
Peers
Comparison fields: 5 of 60
- Hematology 519
- Genetics 218
- Emergency Medicine 68
- Orthopedics and Sports Medicine 45
- Pulmonary and Respiratory Medicine 104
Countries citing papers authored by C. Aul
This map shows the geographic impact of C. Aul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Aul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Aul more than expected).
Fields of papers citing papers by C. Aul
This network shows the impact of papers produced by C. Aul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Aul. The network helps show where C. Aul may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Aul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. | 1992 | 222 |
| 2 | Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. | 1994 | 80 |
| 3 | 1993 | 47 | |
| 4 | 2007 | 47 | |
| 5 | 2002 | 46 | |
| 6 | Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf score. | 1994 | 42 |
| 7 | Detection of the ageing-associated 5-Kb common deletion of mitochondrial DNA in blood and bone marrow of hematologically normal adults. Absence of the deletion in clonal bone marrow disorders. | 1995 | 29 |
| 8 | [Secondary hemochromatosis in polytransfused patients with myelodysplastic syndromes]. | 1992 | 28 |
| 9 | 2002 | 26 | |
| 10 | Is acquired idiopathic sideroblastic anemia (AISA) a disorder of mitochondrial DNA? | 1993 | 25 |
| 11 | Levels of circulating endothelial adhesion molecules (sE-selectin and sVCAM-1) in adult patients with acute leukemia. | 1996 | 21 |
| 12 | [Effect of valve type and valve function on chronic intravascular hemolysis after alloprosthetic mitral and aortic valve replacement]. | 1983 | 21 |
| 13 | 2017 | 17 | |
| 14 | Congenital asplenia detected in a 60 year old patient with septicemia. | 1999 | 17 |
| 15 | 1997 | 16 | |
| 16 | Long-term survival of recipients of allogeneic bone-marrow transplantation after mechanical ventilation. | 1997 | 14 |
| 17 | 1991 | 13 | |
| 18 | 1990 | 9 | |
| 19 | T-PLL-1 protocol of the German CLL study group (GCLLSG) - a prospective phase II trial of fludarabine phosphate, mitoxantrone and cyclophosphamide (FMC) followed by alemtuzumab consolidation as first-line treatment in T-PLL. | 2003 | 7 |
| 20 | Idarubicin, melphalan and cyclophosphamide: an intensified high-dose regimen for the treatment of myeloma patients. | 1997 | 7 |
About C. Aul
C. Aul is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 764 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (18 papers), Multiple Myeloma Research and Treatments (5 papers), Retinoids in leukemia and cellular processes (4 papers), Metabolism and Genetic Disorders (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Neutropenia and Cancer Infections (3 papers). The work is most often cited by research in Hematology (519 citations), Genetics (218 citations), Emergency Medicine (68 citations), Orthopedics and Sports Medicine (45 citations) and Pulmonary and Respiratory Medicine (104 citations). C. Aul has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Norbert Gattermann, Wolfgang Schneider, Ulrich Germing, A. Heyll, G. Derigs, Volker Runde, D. Söhngen, W Schneider, Aristoteles Giagounidis and Matthias Leschke. Their work appears in journals such as Leukemia Research, Annals of Hematology, Blood, Haematologica and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.